Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib Malate Combined With Camrelizumab for Recurrent and Metastatic Cervical Cancer
NCT07143292Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of famitinib in Cervical Cancer (CC), sponsored by Sun Yat-sen Memorial Hospital. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
famitinib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07143292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07143292.